CRO of PharmaTechnology R&D
1、Cooperative development or commissioned development of new drug；
2、Process development of API & Intermediate；
3、Impurities synthesis and preparation
4、Environment-friendly process improvement & process research for Large-scale production —— Biocatalysis technology
New drug declared in 2013-2014:
|
Project Name |
Registration Categories |
Indications |
Admissibility |
R&D progress |
|
Ramelteon Tablets |
3.1 |
Insomnia |
|
Clinical Declaration |
|
Canagliflozin Tablets |
3.1 |
Diabetes |
|
Clinical Declaration |
|
Olanzapine fluoxetine capsules |
3.2 |
Anxiety |
|
Clinical Declaration |
|
Dapagliflozin Tablets |
3.1 |
Diabetes |
|
Clinical Declaration |
|
mirabegron, stained-release tablets |
3.1 |
Incontinence |
|
Clinical Declaration |
|
Phosphorus fluconazole injection |
3.1 |
Antifungal |
|
Clinical Declaration |
|
Retapamulin Ointment |
3.1 |
Antibiotic |
|
Clinical Declaration |
